Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study (original) (raw)

Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement

Mohammed Adawi

Clinical Rheumatology, 2020

View PDFchevron_right

The Correlation between Allergic Diseases and Systemic Lupus Erythematosus

Yulyani Werdiningsih

Indonesian Journal of Medicine

View PDFchevron_right

Assessment of lupus: where are we now?

P. Caroline Gordon

Annals of the Rheumatic Diseases, 1993

View PDFchevron_right

Response criteria for cutaneous SLE in clincal trials

matthew liang

2007

View PDFchevron_right

Predictive potential of the disease activity index and C-reactive protein for infection in systemic lupus erythematosus patients

Sherif Gamal

The Egyptian Rheumatologist, 2015

View PDFchevron_right

Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease

Laura martinez

Journal of Clinical Medicine, 2021

View PDFchevron_right

Association of Smoking With Cutaneous Manifestations in Systemic Lupus Erythematosus

Earl Silverman

Arthritis Care & Research, 2013

View PDFchevron_right

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

LAWRENCE joseph

Arthritis and Rheumatism, 1996

View PDFchevron_right

EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

Barbara Giovannone

Journal of Allergy and Clinical Immunology

View PDFchevron_right

Abrahamovych U., Abrahamovych O., Nadashkevych O., Svintsitskyi A., Synenkyi O. Diagnostic value of systemic lupus erythematosus classification criteria (American College of Rheumatology, 1997) // International Academy Journal Web of Scholar. – 2020. – № 4. – P. 17–22.

Anatoliy Svintsitskyy

Diagnostic value of systemic lupus erythematosus classification criteria (American College of Rheumatology, 1997), 2020

View PDFchevron_right

Autologous serum skin test response in chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level

Ali Alatas

Archives of Dermatological Research

View PDFchevron_right

Potential Immune Biomarkers in Diagnosis and Clinical Management for Systemic Lupus Erythematosus

Nesina Avdagić

Journal of Medical Biochemistry, 2018

View PDFchevron_right

Role of Eosinophil Relative Count and Neutrophil-to-Lymphocyte Ratio in the Assessment of Severity of Atopic Dermatitis

Yozo Ishiuji

Acta Dermato Venereologica

View PDFchevron_right

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions

Emilia Sato

Clinics, 2011

View PDFchevron_right

Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients

Hossein Hadinedoushan

Lung India, 2012

View PDFchevron_right

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions

Emília Sato

Clinics, 2011

View PDFchevron_right

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology

Jacqueline Junkins-hopkins

Arthritis & Rheumatism, 2008

View PDFchevron_right

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease

Barbara Giovannone

The Journal of allergy and clinical immunology, 2018

View PDFchevron_right

Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI

A. Meuth, Esther Kuehn

Journal of the European Academy of Dermatology and Venereology, 2011

View PDFchevron_right

Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis

Anita Remitz

Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 2006

View PDFchevron_right

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Website

Lihi Eder

The Journal of Rheumatology, 2013

View PDFchevron_right

Serum and urinary cytokine levels of SLE patients

Boglarka Brugos

Die Pharmazie, 2012

View PDFchevron_right

Exhaled IL-8 in Systemic Lupus Erythematosus with and without Pulmonary Fibrosis

Tadeusz Pietras

Archivum Immunologiae et Therapiae Experimentalis, 2014

View PDFchevron_right

Monitoring of Disease Biomarkers Activity and Immunophenotyping as Important Factors in SLE Clinical Management

Izet Eminovic

Medical Archives, 2012

View PDFchevron_right

Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)

Anna Zalewska-Janowska

Autoimmunity Reviews, 2013

View PDFchevron_right

A panel of biomarkers for disease severity in atopic dermatitis

Edward Knol

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015

View PDFchevron_right

Lupus Erythematosus to Measure Disease Activity

Zahi Touma

2016

View PDFchevron_right

Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus

G. Soardo

Annals of the Rheumatic Diseases, 1980

View PDFchevron_right

Distinguishing infectionsvsflares in patients with systemic lupus erythematosus: Table 1

Carlos Cañas

Rheumatology, 2016

View PDFchevron_right

Revised Cutaneous Lupus erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus

A. Meuth

British Journal of Dermatology, 2010

View PDFchevron_right

Immune deposits in normal skin of patients with systemic lupus erythematosus: Relationship to the serum capacity to solubilize immune complexes

Angelo Corvetta

Clinical Immunology and Immunopathology, 1985

View PDFchevron_right